Clinical Trials Browser

Phase 2 × GI Cancers × Oxaliplatin × Clear all

NCT06648785 2026-02-05

Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies

Phase 2 Enrolling by invitation

GI Cancers